Incraft (R) AAA Stent Graft System

System, Endovascular Graft, Aortic Aneurysm Treatment

FDA Premarket Approval P150002 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

The movement of the manufacturing facility for a critical supplier

DeviceIncraft (R) AAA Stent Graft System
Classification NameSystem, Endovascular Graft, Aortic Aneurysm Treatment
Generic NameSystem, Endovascular Graft, Aortic Aneurysm Treatment
ApplicantCordis Corporation
Date Received2019-05-24
Decision Date2019-06-21
PMAP150002
SupplementS003
Product CodeMIH
Advisory CommitteeCardiovascular
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Cordis Corporation 6500 Paseo Padre Pkwy fremont, CA 94555

Supplemental Filings

Supplement NumberDateSupplement Type
P150002Original Filing
S010 2021-04-26 30-day Notice
S009
S008 2020-03-31 Normal 180 Day Track No User Fee
S007 2019-08-12 135 Review Track For 30-day Notice
S006 2019-07-22 30-day Notice
S005 2019-06-10 30-day Notice
S004 2019-05-24 30-day Notice
S003 2019-05-24 30-day Notice
S002 2019-05-01 30-day Notice
S001 2019-01-25 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.